1,007
Views
43
CrossRef citations to date
0
Altmetric
HORMONE PROFILING FOR THE DIAGNOSIS OF PCOS AND PHENOTYPES CHARACTERIZATION

Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes

ORCID Icon, , , , , , , , , & show all
Pages 595-600 | Received 29 May 2018, Accepted 13 Dec 2018, Published online: 22 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Aida Fallahzadeh, Fahimeh Ramezeni Tehrani, Malihe Rezaee, Fatemeh Mahboobifard & Mina Amiri. (2023) Anti-Mullerian hormone and cardiometabolic status: a systematic review. Biomarkers 28:6, pages 486-501.
Read now
Tufan Arslanca, Tolga Ecemis, Mine Kiseli, Esra Arslanoglu, Mustafa S. Kotanoğlu & Gamze S. Caglar. (2022) Pregnancy outcome of freeze thaw cycles of polycystic ovary syndrome patients regarding the anti-Müllerian hormone percentile. Journal of Obstetrics and Gynaecology 42:5, pages 1319-1324.
Read now
María T. Prieto-Sánchez, Ana I. Hernández-Peñalver, María L. Sánchez-Ferrer, Jaime Mendiola & Alberto M. Torres-Cantero. (2022) Anogenital distance and anti-Müllerian hormone combined improves the diagnosis of polycystic ovary syndrome. Human Fertility 25:2, pages 274-282.
Read now
Yu Ran, Qiang Yi & Cong Li. (2021) The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups. Diabetes, Metabolic Syndrome and Obesity 14, pages 1419-1424.
Read now
Ayşegül Mut, Cemal Tamer Erel, Deniz İnan & Yahya Özgün Öner. (2021) Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome. Gynecological Endocrinology 37:5, pages 462-466.
Read now
Başak Güler, Sibel Özler, Nezaket Kadıoğlu, Eda Özkan, Merve Sibel Güngören & Şevki Çelen. (2020) Is the low AMH level associated with the risk of cardiovascular disease in obese pregnants?. Journal of Obstetrics and Gynaecology 40:7, pages 912-917.
Read now
Monica Gupta, Ritu Yadav, Reeta Mahey, Anisha Agrawal, Ashish Upadhyay, Neena Malhotra & Neerja Bhatla. (2019) Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes – a cross-sectional study. Gynecological Endocrinology 35:11, pages 970-973.
Read now

Articles from other publishers (36)

Manfei Si, Wanxue Xu, Xinyu Qi, Huahua Jiang, Yue Zhao, Rong Li, Xiaoyu Long & Jie Qiao. (2023) Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS Classifications. Journal of Clinical Medicine 12:15, pages 5073.
Crossref
Terhi T Piltonen, Elina Komsi, Laure C Morin-Papunen, Elisa Korhonen, Stephen Franks, Marjo-Riitta Järvelin, Riikka K Arffman & Meri-Maija Ollila. (2023) AMH as part of the diagnostic PCOS workup in large epidemiological studies. European Journal of Endocrinology 188:6, pages 547-554.
Crossref
Lidia Rosi Medeiros, Tamy Colonetti, Erickson Cardoso Nagib, Maria Laura Rodrigues Uggioni, João Carlos Denoni Junior, Luciane Ceretta, Antonio José Grande & Maria Inês Rosa. (2023) Anti-Müllerian Hormone levels after metformin treatment in polycystic ovary syndrome: A systematic review and meta-analysis. Obesity Research & Clinical Practice.
Crossref
Subarna Mitra, Gautom K. Saharia & Saubhagya K. Jena. (2023) Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS. Annales d'Endocrinologie.
Crossref
Menghui Zhang, Xiaocong Liu, Xiaolu Xu, Jing Li, Zhiqin Bu, Qingling Yang, Hao Shi, Wenbin Niu, Shanjun Dai, Yuling Liang & Yihong Guo. (2023) The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study. Reproductive Biology and Endocrinology 21:1.
Crossref
Minhthao Thi Nguyen, Sridevi Krishnan, Sonal V. Phatak & Sidika E. Karakas. (2023) Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics. Diagnostics 13:3, pages 500.
Crossref
Rebecca H K Emanuel, Paul D Docherty, Helen Lunt & Rebecca E Campbell. (2022) Comparing Literature-Derived and Subreddit-Derived Laboratory Values in Polycystic Ovary Syndrome (PCOS): Validation of Clinical Data Posted on PCOS Reddit Forums (Preprint). JMIR Formative Research.
Crossref
Muhammad Salman Butt, Javeria Saleem, Sobia Aiman, Rubeena Zakar, Iftikhar Sadique & Florian Fischer. (2022) Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age. BMC Women's Health 22:1.
Crossref
R. Muharam, Yohanes Danang Prasetyo, Kevin Ardito Prabowo, Yuannita Ika Putri, Mila Maidarti & Andon Hestiantoro. (2022) IVF outcome with a high level of AMH: a focus on PCOS versus non-PCOS. BMC Women's Health 22:1.
Crossref
Begum Aydogan Mathyk, Esra Cetin & Bulent O. Yildiz. (2022) Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 29:6, pages 528-534.
Crossref
Türkan Gürsu, Alper Eraslan & Berk Angun. (2022) Comparison of body mass index, anti-müllerian hormone and insulin resistance parameters among different phenotypes of polycystic ovary syndrome. Gynecology and Obstetrics Clinical Medicine 2:4, pages 164-170.
Crossref
Josefin Kataoka, Ingrid Larsson, Eva Lindgren, Li Oskarson Kindstrand, Johanna Schmidt & Elisabet Stener-Victorin. (2022) Circulating Anti-Müllerian hormone in a cohort-study of women with severe obesity with and without polycystic ovary syndrome and the effect of a one-year weight loss intervention. Reproductive Biology and Endocrinology 20:1.
Crossref
Koushik Bhattacharya, Ishita Saha, Debanjana Sen, Chaitali Bose, Gargi Ray Chaudhuri, Sulagna Dutta, Pallav Sengupta, Soumita Bhattacharya, Sharit Shekhar Barman & Alak Kumar Syamal. (2022) Role of anti-Mullerian hormone in polycystic ovary syndrome. Middle East Fertility Society Journal 27:1.
Crossref
Elena V. BOLOTOVA, Anna V. DUDNIKOVA, Fedor E. FILIPPOV, Victoria A. KRUTOVA, Natalia S. PROSOLUPOVA & Anzhelika А. SOROCHENKO. (2022) Features of metabolic disorders in women with polycystic ovary syndrome combined with obesity. Gazzetta Medica Italiana Archivio per le Scienze Mediche 181:5.
Crossref
Shikha Anand, Amit Kumar, Anupa Prasad & Kiran Trivedi. (2022) Updated meta‐analysis on the diagnostic accuracy of serum anti‐Mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects. Journal of Obstetrics and Gynaecology Research 48:8, pages 2162-2174.
Crossref
I. S. Zakharov, A. A. Schmidt, S. V. Beskrovny & V. G. Abashin. (2022) Differential diagnosis of hyperandrogenism syndrome and the possibility of its correction. Clinical Medicine (Russian Journal) 100:4-5, pages 165-172.
Crossref
Xiaoming Pan, Yinger Gu, Xian Zhang, Biwei Shi, Long Cui, Fangfang Wang & Fan Qu. (2022) Chinese herbal medicine (Bu-Shen-Tian-Jing Formula) for outcomes of IVF in Chinese patients with polycystic ovary syndrome: A retrospective cohort study. Integrative Medicine Research 11:1, pages 100775.
Crossref
L. V. Adamyan, E. N. Andreeva, Yu. S. Absatarova, O. R. Grigoryan, I. I. Dedov, G. A. Melnichenko, L. V. Suturina, O. S. Filippov, E. V. Sheremetyeva, G. E. Chernukha & M. I. Yarmolinskaya. (2022) Clinical guidelines «Polycystic Ovary Syndrome». Problems of Endocrinology 68:2, pages 112-127.
Crossref
利君 刘. (2022) Relevant Application of Anti-Mullerian Hormone in Reproductive Field. Advances in Clinical Medicine 12:08, pages 7053-7058.
Crossref
Ruth G. Freeman. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 121 132 .
Fahimeh Ramezani Tehrani, Maryam Rahmati, Fatemeh Mahboobifard, Faezeh Firouzi, Nazanin Hashemi & Fereidoun Azizi. (2021) Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome. Reproductive Biology and Endocrinology 19:1.
Crossref
Nathalie di Clemente, Chrystèle Racine, Alice Pierre & Joëlle Taieb. (2021) Anti-Müllerian Hormone in Female Reproduction. Endocrine Reviews 42:6, pages 753-782.
Crossref
E. V. Bolotova, A. V. Dudnikova, V. A. Krutova & N. S. Prosolupova. (2021) The frequency and structure of metabolic disorders in obese women in combination with polycystic ovary syndrome. Obesity and metabolism 18:3, pages 254-262.
Crossref
O.A. Burka, T.M. Tutchenko, O.M. Kudlai, T.V. Shevchuk, O.V. Protsenko & O.M. Makarovets. (2021) Application areas of modern automated methods of anti-Müllerian hormone evaluation. REPRODUCTIVE ENDOCRINOLOGY:59, pages 85-91.
Crossref
Anupama Bahadur, Neha Verma, Rajlaxmi Mundhra, Latika Chawla, Megha Ajmani, Modalavalasa Swetha Sri & Shivaani Arora. (2021) Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome. Cureus.
Crossref
Stefano Palomba, Terhi T Piltonen & Linda C Giudice. (2021) Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Human Reproduction Update 27:3, pages 584-618.
Crossref
Chang Chu, Oleg Tsuprykov, Xin Chen, Saban Elitok, Bernhard K. Krämer & Berthold Hocher. (2021) Relationship Between Vitamin D and Hormones Important for Human Fertility in Reproductive-Aged Women. Frontiers in Endocrinology 12.
Crossref
Alexander O. Shpakov. (2021) Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals 14:1, pages 42.
Crossref
Mauro S. B. Silva & Paolo Giacobini. (2020) New insights into anti-Müllerian hormone role in the hypothalamic–pituitary–gonadal axis and neuroendocrine development. Cellular and Molecular Life Sciences 78:1, pages 1-16.
Crossref
Ping-Ping Lv, Min Jin, Jin-Peng Rao, Jian Chen, Li-Quan Wang, Chang-Chang Huang, Song-Qing Yang, Qiu-Ping Yao, Lei Feng, Jin-Ming Shen & Chun Feng. (2020) Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study. BMC Endocrine Disorders 20:1.
Crossref
Menliang Zhu, Qiyang Shen, Xiaolian Li & Jihong Kang. (2020) Removal of peri-ovarian adipose tissue affects follicular development and lipid metabolism†. Biology of Reproduction 103:6, pages 1199-1208.
Crossref
P Peuranpää, H Hautamäki, M Halttunen-Nieminen, C Hydén-Granskog & A Tiitinen. (2020) Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment. Human Reproduction 35:3, pages 504-515.
Crossref
Richard Fleming. (2020) Anti-Müllerian Hormone: A Personal View of the Empowering Analyte. Journal of Human Reproductive Sciences 13:4, pages 257.
Crossref
Ioannis E. Messinis, Christina I. Messini & Konstantinos Dafopoulos. 2020. Obesity and Gynecology. Obesity and Gynecology 23 34 .
Danielle Hiam, David Simar, Rhianna Laker, Ali Altıntaş, Melanie Gibson-Helm, Elly Fletcher, Alba Moreno-Asso, Adam J Trewin, Romain Barres & Nigel K Stepto. (2019) Epigenetic Reprogramming of Immune Cells in Women With PCOS Impact Genes Controlling Reproductive Function. The Journal of Clinical Endocrinology & Metabolism 104:12, pages 6155-6170.
Crossref
О. А. Бурка & Т. М. Тутченко. (2019) Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women. Reproductive Endocrinology 0:46, pages 39-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.